A patient with pantothenate kinase-associated neurodegeneration and supranuclear gaze palsy

Clinical Neurology and Neurosurgery

Volumn 111, Issue 8, 2009, Pages 688-690

  Bozi, Maria ^a,b   Matarin, Mar ^c   Theocharis, Ioannis ^d   Potagas, Costas ^a   Stefanis, Leonidas ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b General Hospital of Syros   (Greece)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d IASO GENERAL HOSPITAL   (Greece)

Author keywords

Eye movement abnormalities; PANK2 mutation; Phenotype; PKAN; Retinopathy; Supranuclear gaze palsy

Indexed keywords

BACLOFEN; PANTOTHENATE CALCIUM; TRIHEXYPHENIDYL;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; EYE EXAMINATION; GAZE PARALYSIS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION; PHENOTYPE;

ADOLESCENT; ADULT; CHILD; DISEASE PROGRESSION; HUMANS; MALE; OCULAR MOTILITY DISORDERS; PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION; RETINITIS PIGMENTOSA; VISION DISORDERS;

EID: 68849093392     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2009.04.007     Document Type: Article

References (16)

1. Zhou B., Westaway S.K., Levinson B., Johnson M.A., Gitschier J., and Hayflick S.J. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 28 (2001) 345-349
2. Hayflick S.J., Westaway S.K., Levinson B., Zhou B., Johnson M.A., Ching K.H., et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 348 (2003) 33-40
3. Egan R.A., Weleber R.G., Hogarth P., Gregory A., Coryell J., Westaway S.K., et al. Neuro-ophthalmologic and electroretinographic findings in pantothenate kinase-associated neurodegeneration (formerly Hallervorden-Spatz syndrome). Am J Ophthalmol 140 (2005) 267-274
4. Burke R.E., Fahn S., Marsden C.D., Bressman S.B., Moskowitz C., and Friedman J. Validity and reliability of a rating scale for the primary torsion dystonias. Neurology 35 (1985) 73-77
5. Castelnau P., Cif L., Valente E.M., Vayssiere N., Hemm S., Gannau A., et al. Pallidal stimulation improves pantothenate kinase-associated neurodegeneration. Ann Neurol 57 (2005) 738-741
6. Hartig M.B., Hortnagel K., Garavaglia B., Zorzi G., Kmiec T., Klopstock T., et al. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol 59 (2006) 248-256
7. Fearnley J.M., Revesz T., Brooks D.J., Frackowiak R.S., and Lees A.J. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry 54 (1991) 159-161
8. Patterson M.C. A riddle wrapped in a mystery: understanding Niemann-Pick disease, type C. Neurologist 9 (2003) 301-310
9. Harris C.M., Taylor D.S., and Vellodi A. Ocular motor abnormalities in Gaucher disease. Neuropediatrics 30 (1999) 289-293
10. Mark M.H., Sage J.I., Walters A.S., Duvoisin R.C., and Miller D.C. Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three cases. Mov Disord 10 (1995) 450-454
11. Masdeu J.C., and Rosenberg M. Midbrain-diencephalic horizontal gaze paresis. J Clin Neuroophthalmol 7 (1987) 227-234
12. Sahashi K., Sakai K., Mano K., and Hirose G. Anti-Ma2 antibody related paraneoplastic limbic/brain stem encephalitis associated with breast cancer expressing Ma1, Ma2, and Ma3 mRNAs. J Neurol Neurosurg Psychiatry 74 (2003) 1332-1335
13. Kiley M., and Esiri M.M. A contemporary case of encephalitis lethargica. Clin Neuropathol 20 (2001) 2-7
14. Magherini A., Pentore R., Grandi M., Leone M.E., and Nichelli P.F. Progressive supranuclear gaze palsy without parkinsonism: a case of neuro-Whipple. Parkinsonism Relat Disord 13 (2007) 449-452
15. Prasad S., Ko M.W., Lee E.B., Gonatas N.K., Stern M.B., and Galetta S. Supranuclear vertical gaze abnormalities in sporadic Creutzfeldt-Jakob disease. J Neurol Sci 253 (2007) 69-72
16. Hayflick S.J., Hartman M., Coryell J., Gitschier J., and Rowley H. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am J Neuroradiol 27 (2006) 1230-1233